Clinical Trials Browser

Phase 1 × Neuroendocrine Tumors × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all

NCT04234568 2026-06-01

Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors

Phase 1 Active not recruiting

31 enrolled 16 charts

Neuroendocrine Tumors